Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes

被引:144
作者
Brugarolas, J
Kaelin, WG
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1016/j.ccr.2004.06.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The LKB1 tumor suppressor protein controls the activity of the TSC1/TSC2 tumor suppressor complex. Mutations in LKB1 cause Peutz-Jeghers syndrome (PJS), and mutations in either TSC1 or TSC2 cause tuberous sclerosis complex-two syndromes characterized by the development of hamartomas. LKB1 activation by energy deprivation activates AMPK, which in turn phosphorylates and activates TSC2. TSC2 activation results in the inactivation of mTOR, a critical regulator of protein translation. How mTOR dysregulation after inactivation of LKB1 or TSC1/2 contributes to hamartoma development is not known. However, hypoxia-inducible factor (HIF) and VEGF are regulated by mTOR and are likely to play a contributory role.
引用
收藏
页码:7 / 10
页数:4
相关论文
共 47 条
[1]   Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer [J].
Anand, N ;
Murthy, S ;
Amann, G ;
Wernick, M ;
Porter, LA ;
Cukier, IH ;
Collins, C ;
Gray, JW ;
Diebold, J ;
Demetrick, DJ ;
Lee, JM .
NATURE GENETICS, 2002, 31 (03) :301-305
[2]   Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells [J].
Avdulov, S ;
Li, S ;
Michalek, V ;
Burrichter, D ;
Peterson, M ;
Perlman, DM ;
Manivel, JC ;
Sonenberg, N ;
Yee, D ;
Bitterman, PB ;
Polunovsky, VA .
CANCER CELL, 2004, 5 (06) :553-563
[3]   Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation [J].
Bardeesy, N ;
Sinha, M ;
Hezel, AF ;
Signoretti, S ;
Hathaway, NA ;
Sharpless, NE ;
Loda, M ;
Carrasco, DR ;
DePinho, RA .
NATURE, 2002, 419 (6903) :162-167
[4]   LKB1, a protein kinase regulating cell proliferation and polarity [J].
Boudeau, J ;
Sapkota, G ;
Alessi, DR .
FEBS LETTERS, 2003, 546 (01) :159-165
[5]   TSC2 regulates VEGF through mTOR-dependent and -independent pathways [J].
Brugarolas, JB ;
Vazquez, F ;
Reddy, A ;
Sellers, WR ;
Kaelin, WG .
CANCER CELL, 2003, 4 (02) :147-158
[6]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[7]   The AMP-activated protein kinase cascade - a unifying system for energy control [J].
Carling, D .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (01) :18-24
[8]   Molecular genetic advances in tuberous sclerosis [J].
Cheadle, JP ;
Reeve, MP ;
Sampson, JR ;
Kwiatkowski, DJ .
HUMAN GENETICS, 2000, 107 (02) :97-114
[9]  
CORRANDEI MN, 2004, IN PRESS GENES DEV
[10]   Oncogenic alterations of metabolism [J].
Dang, CV ;
Semenza, GL .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :68-72